Menon K, Romagnuolo J, Barkun A N
Division of Gastroenterology, McGill University and the McGill University Health Centre, Montreal, Quebec, Canada.
Am J Gastroenterol. 2001 May;96(5):1435-40. doi: 10.1111/j.1572-0241.2001.03795.x.
Expandable metal stents are currently used to treat biliary tract obstruction. Few data exist on the role of metal stents in patients with recurrent premature plastic biliary stent occlusion. We report our preliminary results using an expandable metal biliary stent with enhanced stent flexibility in this group of patients. Our aim was to assess the efficacy of the Diamond biliary stent in the treatment of recurrent premature biliary plastic stent blockage.
From September 1997 to June 1998, six patients with inoperable biliary obstruction and at least one prior episode of plastic stent occlusion were treated with an expandable metal biliary prosthesis. There were four women and six men, with a mean age of 73+/-11 yr. Five patients had malignant biliary obstruction, and one inoperable patient had a biliary stricture secondary to chronic pancreatitis. Patients were followed-up prospectively until either stent occlusion or death. The patency duration of the metal stents was compared to that of the most recently placed plastic stents.
All stents were successfully inserted endoscopically with visualized biliary drainage. No significant immediate postprocedural complications were noted. Median time from initial diagnosis of biliary obstruction to metal stent insertion was 35 wk (range 7-142), during which time patients had occluded a median of 4.5 plastic stents (range 2-5). Median patient survival was 117 days (15-312) and median time to blockage of the last plastic stent was 25.5 days (range 10-90 days). Three cases of metal stent occlusion occurred. One patient had early stent occlusion at 9 days because of debris and sludge clogging the metal stent. Two other patients developed stent occlusion at 120 and 157 days. Two stents remained patent until the patients' deaths at 15 and 87 days. Overall median stent patency was 139 days. The three patients who developed stent occlusion were treated with successful insertion of one or more plastic stents through the existing metal stent. Duration of metal stent patency was significantly longer than that of the last plastic stent (58.8 days longer; 95% CI [6.4, 111]; p = 0.03).
Metal biliary prostheses represent an effective management strategy for recurrent plastic biliary stent obstruction. Patients in this subgroup may have a shorter duration of metal stent patency than the reported duration of stent patency in patients receiving initial metal stent placement. However the duration of patency still seems to be significantly longer than that of the most recently placed plastic stent.
可扩张金属支架目前用于治疗胆道梗阻。关于金属支架在复发性早期塑料胆道支架闭塞患者中的作用,相关数据较少。我们报告了在这组患者中使用具有增强支架柔韧性的可扩张金属胆道支架的初步结果。我们的目的是评估钻石胆道支架在治疗复发性早期胆道塑料支架阻塞中的疗效。
1997年9月至1998年6月,6例无法手术的胆道梗阻患者,且至少有一次先前塑料支架闭塞发作,接受了可扩张金属胆道假体治疗。其中有4名女性和6名男性,平均年龄为73±11岁。5例患者患有恶性胆道梗阻,1例无法手术的患者患有慢性胰腺炎继发的胆道狭窄。对患者进行前瞻性随访,直至支架闭塞或死亡。将金属支架的通畅持续时间与最近放置的塑料支架的通畅持续时间进行比较。
所有支架均通过内镜成功插入,实现了可视化胆道引流。术后未发现明显的即时并发症。从胆道梗阻初步诊断到金属支架插入的中位时间为35周(范围7 - 142周),在此期间患者平均闭塞了4.5个塑料支架(范围2 - 5个)。患者的中位生存期为117天(15 - 312天),最后一个塑料支架闭塞的中位时间为25.5天(范围10 - 90天)。发生了3例金属支架闭塞。1例患者在9天时因碎片和淤泥堵塞金属支架而早期支架闭塞。另外2例患者分别在120天和157天时发生支架闭塞。2个支架在患者分别于15天和87天死亡时仍保持通畅。总体支架中位通畅时间为139天。发生支架闭塞的3例患者通过经现有金属支架成功插入一个或多个塑料支架进行了治疗。金属支架的通畅持续时间明显长于最后一个塑料支架(长58.8天;95%置信区间[6.4, 111];p = 0.03)。
金属胆道假体是复发性塑料胆道支架阻塞的一种有效管理策略。该亚组患者的金属支架通畅持续时间可能比接受初始金属支架置入的患者报告的支架通畅持续时间短。然而,通畅持续时间似乎仍明显长于最近放置的塑料支架。